본문 바로가기
investors

SOTIO Expands its Antibody-Drug Conjugate Pipeline with Exclusive Collaboration and License Agreement with LegoChem Biosciences

2021.11.17

https://www.b3cnewswire.com/202111162287/sotio-expands-its-antibody-drug-conjugate-pipeline-with-exclusive-collaboration-and-license-agreement-with-legochem-biosciences.html